This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Mar 31;544(7648):13-14.

doi: 10.1038/nature.2017.21755.

Promising cancer drugs may speed tumours in some patients

PMID: 28383004
DOI: 10.1038/nature.2017.21755

Comment

Promising cancer drugs may speed tumours in some patients

Heidi Ledford. Nature. 2017.

. 2017 Mar 31;544(7648):13-14.

doi: 10.1038/nature.2017.21755.

Author

PMID: 28383004
DOI: 10.1038/nature.2017.21755

No abstract available

PubMed Disclaimer

Comment on

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia.
Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpas M, Trujillo JM, Blick M, Beran M, Gutterman JU. Kurzrock R, et al. Nature. 1987 Feb 12-18;325(6105):631-5. doi: 10.1038/325631a0. Nature. 1987. PMID: 3543692
iRECIST: A clarification of tumour response assessment in the immunotherapy era.
Ferté C, Marabelle A. Ferté C, et al. Eur J Cancer. 2017 May;77:165-167. doi: 10.1016/j.ejca.2017.02.015. Epub 2017 Apr 4. Eur J Cancer. 2017. PMID: 28385325 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations